Precision diagnosis of hepatocellular carcinoma.
10.1097/CM9.0000000000002641
- VernacularTitle:Precision diagnosis of hepatocellular carcinoma
- Author:
Zhenxiao WANG
1
;
Hanjiao QIN
2
;
Shui LIU
1
;
Jiyao SHENG
1
;
Xuewen ZHANG
1
Author Information
1. Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, Jilin 130041, China.
2. Department of Radiotherapy, Second Hospital of Jilin University, Changchun, Jilin 130041, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Carcinoma, Hepatocellular/pathology*;
Liver Neoplasms/pathology*;
Prognosis;
Early Diagnosis;
Precision Medicine
- From:
Chinese Medical Journal
2023;136(10):1155-1165
- CountryChina
- Language:English
-
Abstract:
Hepatocellular carcinoma (HCC) is the most common type of primary hepatocellular carcinoma (PHC). Early diagnosis of HCC remains the key to improve the prognosis. In recent years, with the promotion of the concept of precision medicine and more in-depth analysis of the biological mechanism underlying HCC, new diagnostic methods, including emerging serum markers, liquid biopsies, molecular diagnosis, and advances in imaging (novel contrast agents and radiomics), have emerged one after another. Herein, we reviewed and analyzed scientific advances in the early diagnosis of HCC and discussed their application and shortcomings. This review aimed to provide a reference for scientific research and clinical practice of HCC.
